Your panel recommended ultimately broadening the system to a universal public coverage of medicines listed on a new national formulary. You recommended that this formulary be extensive enough to accommodate the full range of individual patient needs, including rare diseases.
I also note that the principles identified by the panel either are the same principles or a mirror or are compatible with the principles under the Canada Health Act.
I am curious about your views on whether the panel would like to see the creation of a national public insurance system as a standalone system, with a national formulary administered on its own, or whether it sees an expansion of insured services under the Canada Health Act, under the present system of delivery. Or is there any big difference between the two?